Global Amoxicillin sodium Market size-
Industry Trends & Forecast Report 2027.
The global amoxicillin sodium market is estimated to reach USD
679.1 million by 2020 and is further projected to reach USD 905.2 million by
2027, growing at a CAGR of 4.9% during 2021-2027 (forecast period). The
amoxicillin sodium market is likely to grow in the forecast timeframe due to
the growing bacterial infections. Amoxicillin sodium is a common antibiotic
used to treat several bacterial infections. These infections include middle ear
infections, strep throat, pneumonia, skin infections, and urinary tract
infections among others. It is taken by mouth, or less commonly by injection.
Amoxicillin is a common bactericidal drug i.e.,it does not directly kill the
bacteria but instead stops the bacteria from multiplying.
Source: BlueWeave Consulting
Global Amoxicillin sodium Market Overview:
Amoxicillin Sodium is defined as the sodium salt form of a
broad-spectrum. It is categorized as a semisynthetic aminopenicillin antibiotic
with bactericidal activity. Amoxicillin binds and inactivates
penicillin-binding proteins that are located on the inner membrane of the
bacterial cell wall. This medication is a penicillin-type antibiotic. It functions
by stopping the growth of bacteria. This antibiotic doesn't work for viral
infections (such as the common cold, flu). Amoxicillin Sodium is also used with
other medications to treat stomach/intestinal ulcers that are caused by the
bacteria H. pylori.
Amoxicillin sodium Market Forecast and
Growing Bacterial Infections
The growing bacterial infections are driving the demand for
amoxicillin sodium in the market. For instance, In the U.S.,
antibiotic-resistant bacteria cause at least 2 million infections in the last
years and 23,000 deaths a year resulting in a $55–70 billion per year economic
impact. These antibiotics are critical to the success of surgical procedures
including orthopedic prosthetic surgeries. The symptoms associated with
bacterial infection may persist longer than the expected 10-14 days a virus
tends to last. Fever is higher than one might typically expect from a virus.
Fever gets worse a few days into the illness rather than improving.
Benefits of using amoxicillin sodium
Amoxicillin is a common antibiotic and belongs to the class of
penicillin. it is effective against various bacteria such as Streptococcus,
Staphylococcus, H. influenzae, N. gonorrhea, E. coli, Pneumococci, and many
others. The food and drug administration approved Amoxicillin in December 1974.
Amoxicillin is a bactericidal drug i.e., it does not directly kill the bacteria
but instead stops the bacteria from multiplying and its growth doesn't
replicate. Amoxicillin acts by inhibiting bacterial cell wall synthesis. The
cell wall is necessary to protect the bacteria from the external environment
and keeps the bacteria safe. Hence, the bacteria can't survive without a cell
Side effects associated with amoxicillin
There are various side effects associated with the use of
amoxicillin sodium and this factor can hamper the growth of the market. The
electrolyte disturbances such as hypokalaemia (due to administration of large
amounts of sodium). Hyperkinesia, dizziness, and convulsions Signs of central
nervous system toxicity; generally associated with large intravenous doses of
amoxicillin and even impaired renal function are the most common side effects
of amoxicillin sodium. It upsets the empty stomach, thus necessary to take it
with food. Amoxicillin can also alter the normal and healthy bacteria in the
colon and lead to overgrowth of Clostridium difficile bacteria. This leads to
inflammation of the colon known as pseudomembranous colitis.
Impact of COVID-19 in industry
The global economy and humanity have been pushed into a crisis
due to the COVID-19 pandemic. Due to the high infection rate and adverse impact
on public health systems, various governments have enforced nationwide
lockdowns significantly impacting manufacturing supply chains, trade, and
related services. Players are currently considering digital solutions that
would enable them to serve the community and provide new opportunities to do
business. The production, manufacturing, supply chain, and other operations,
have slowed down globally aimed to limit the spread of the coronavirus,
The global impact of the coronavirus disease 2019 (COVID-19) is
likely only beginning and would significantly affect the Amoxicillin sodium
market in 2020. The outbreak of COVID-19 has brought with it travel bans and
quarantines; massive slowing of the supply chain; uncertainty in the stock
market; falling business confidence, and growing panic among the population.
Despite the growing uncertainty and panic, technology suppliers must continue
to focus on their long-term investments, maintain engagement with partners and
prospects, and look to specific markets for stability.
Amoxicillin sodium Market: By Route of
Based on the route of administration, the Amoxicillin sodium
market is segmented into the capsule, tablet, and Injection. The Injection
segment is likely to dominate in the market followed by capsules. Amoxicillin
may be removed from the circulation by hemodialysis. Though, the standard
recommended for amoxicillin sodium route of administration is by intravenous
injection or intravenous infusion. Otherwise, Intramuscular administration
should only be considered when the intravenous route is not possible or less
appropriate for the patient. The drug got absorbed in the duodenum and jejunum
along with no significant differences in absorption when administered as a
bolus or 4-hour infusion.
Source: BlueWeave Consulting
Amoxicillin sodium Market:
America region is likely to dominate in the Amoxicillin sodium market, followed
by the Asia Pacific, and others. Developing countries like the US and Canada
have major opportunities for industrial production, retail sales, and
fixed-asset investment for Amoxicillin sodium. Several other economies such as
Indonesia, the Philippines, and Singapore in the Asia Pacific region are also
forecast to grow at modest rates. The company's productivity is directly
proportional to the productivity of workers. Hence, businesses in these regions
are commonly embracing different instruments to help workers increase their
Source: BlueWeave Consulting
In 2019, the FDA approved a
new antibiotic that can treat community-acquired bacterial pneumonia. The U.S.
Food and Drug Administration today approved Xenleta (lefamulin) to treat adults
with community-acquired bacterial pneumonia.
The recent studies discovered
that taking probiotics during and after a course of antibiotics can help reduce
the risk of diarrhea and restore the gut microbiota to a healthy state.
The Amoxicillin sodium market is fragmented
owing to the presence of several companies that provides varied Amoxicillin
sodium products. However, the companies that hold the majority share of the
Amoxicillin sodium market are GlaxoSmithKline, Pfizer PLC, Bayer AG, Novartis
AG, and Abbott Inc., Toku-e, Abcam, Alfa Aesar, Tul, Hayao, Cspc, Eli Lilly And
Company, Merck, CSPC, and others, prominent players.
In the Amoxicillin sodium market, prominent
market participants compete based on price and product quality. Small and
medium-sized market players are expected to show considerable improvements in
the foreseeable future, given the moderate level of capital expenditure needed
to set up a business. The large-sized companies, however, are likely to aim for
global expansion, in a bid to gain a more considerable brand reputation.
Scope of the Report
Historical data – 2016-2019
Base Year – 2020
Forecast – 2021 – 2027
Revenue in USD Million
Canada, Germany, UK, France, Italy, Spain, Russia, Brazil, Japan, South
Korea, China, UAE, South Africa, UAE, Turkey, India, Rest of APAC, Mexico,
Argentina, Rest of Latin America, Saudi Arabia, Rest of MEA, Rest of Europe,
By Route of Administration, By application, and
Pfizer PLC, Bayer AG, Novartis AG, and Abbott Inc., Toku-e, Abcam, Alfa
Aesar, Tul, Hayao,Cspc, Eli Lilly And Company,Merck, CSPC, and
Scope of the Report
By Route of
Middle East and Africa